This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Futrell, N. Articles by Millikan, C. Search for Related Content PubMed PubMed Citation Articles by Futrell, N. Articles by Millikan, C. Pubmed/NCBI databases Medline Plus Health Information Lupus

Stroke, Vol 20, 583-591, Copyright © 1989 by American Heart Association

ARTICLES

Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus

N Futrell and C Millikan
Department of Neurology, University of Miami, Florida.

We retrospectively and prospectively reviewed the incidence of stroke in 105 patients with systemic lupus erythematosus (SLE). Stroke occurred in 14 (15%) of 91 consecutive patients with documented SLE; nine (64%) of the 14 had multiple cerebral infarcts. Factors associated with stroke and the frequency of stroke were systemic thrombosis (30%), elevated partial thromboplastin time (36%), spontaneous abortion (50%), age over 60 years (57%), transient ischemic attacks (57%), previous stroke (64%), and cardiac valvular disease (86%). The major period of risk for the first stroke was during the first 5 years of SLE. The most frequent etiology was a cardiogenic embolus or an antibody-mediated hypercoagulable state, with cerebral vasculitis occurring only in association with infection. Because of the decreased fibrinolysis seen in patients with SLE, anticoagulant therapy may be the most effective preventive treatment currently available. Anticoagulant therapy seemed to prevent recurrent focal cerebral ischemia in our patients and was associated with relatively few and minor complications. Patients with a history of transient ischemic attacks or cardiac valvular lesions are at high (57% and 87%, respectively) risk of stroke. Patients who have had a stroke are at high (64%) risk for a recurrent stroke. Anticoagulant therapy is recommended for all of these patients.

This article has been cited by other articles:

				H. Jeong, Y. Kim, W Yoon, S. Joo, S. Lee, and Y. Park Moyamoya syndrome associated with systemic lupus erythematosus Lupus, July 1, 2008; 17(7): 679 - 682. [Abstract] [PDF]

				J. Mikdashi, B. Handwerger, P. Langenberg, M. Miller, and S. Kittner Baseline Disease Activity, Hyperlipidemia, and Hypertension Are Predictive Factors for Ischemic Stroke and Stroke Severity in Systemic Lupus Erythematosus Stroke, February 1, 2007; 38(2): 281 - 285. [Abstract] [Full Text] [PDF]

				T. Kahles, M. Humpich, H. Steinmetz, M. Sitzer, and E. Lindhoff-Last Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke Rheumatology, September 1, 2005; 44(9): 1161 - 1165. [Abstract] [Full Text] [PDF]

				R. Pullmann Jr, M. Skerenova, J. Lukac, J. Hybenova, V. Melus, P. Kubisz, J. Rovensky, and R. Pullmann Factor V Leiden and Prothrombin G20210A Mutations and the Risk of Atherothrombotic Events in Systemic Lupus Erythematosus Clinical and Applied Thrombosis/Hemostasis, July 1, 2004; 10(3): 233 - 238. [Abstract] [PDF]

				R. Bessant, A. Hingorani, L. Patel, A. MacGregor, D. A. Isenberg, and A. Rahman Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus Rheumatology, July 1, 2004; 43(7): 924 - 929. [Abstract] [Full Text] [PDF]

				S Morelli, M L Bernardo, F Viganego, A Sgreccia, P De Marzio, F Conti, R Priori, and G Valesini Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus Lupus, November 1, 2003; 12(11): 805 - 812. [Abstract] [PDF]

				F. G. I. Jennekens and L. Kater The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation Rheumatology, June 1, 2002; 41(6): 605 - 618. [Abstract] [Full Text] [PDF]

				F. G. I. Jennekens and L. Kater The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation Rheumatology, June 1, 2002; 41(6): 619 - 630. [Abstract] [Full Text] [PDF]

				H. Ainiala, J. Loukkola, J. Peltola, M. Korpela, and A. Hietaharju The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus Neurology, August 14, 2001; 57(3): 496 - 500. [Abstract] [Full Text] [PDF]

				K M El Ramahi and H M Al Rayes Systemic lupus erythematosus associated with moyamoya syndrome Lupus, October 1, 2000; 9(8): 632 - 636. [Abstract] [PDF]

				A Mimori, T Suzuki, M Hashimoto, H Nara, T Yoshio, J-I Masuyama, H Okazaki, D Hirata, S Kano, and S Minota Subarachnoid hemorrhage and systemic lupus erythematosus Lupus, September 1, 2000; 9(7): 521 - 526. [Abstract] [PDF]

				A. Ware and A-B. Mongey Lupus and Cerebrovascular Accidents Lupus, January 1, 1997; 6(5): 420 - 424. [PDF]

				C. A. Roldan, B. K. Shively, and M. H. Crawford An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus N. Engl. J. Med., November 7, 1996; 335(19): 1424 - 1430. [Abstract] [Full Text] [PDF]

				A. J. Grau, F. Buggle, C. Steichen-Wiehn, S. Heindl, T. Banerjee, R. Seitz, R. Winter, M. Forsting, E. Werle, C. Bode, et al. Clinical and Biochemical Analysis in Infection-Associated Stroke Stroke, September 1, 1995; 26(9): 1520 - 1526. [Abstract] [Full Text]

				K. Toyoda, H. Tsuji, S. Sadoshima, C. Horimoto, and M. Fujishima Brain Hemorrhage in Mixed Connective Tissue Disease: A Case Report Angiology, November 1, 1994; 45(11): 967 - 972. [Abstract] [PDF]